US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on Jan. 13 for "Substituted pyrazolo[3,4-dpyrimidines as wee-1 inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,607, issued on Jan. 13, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai).

"Substituted pyrazolo[3,4-dpyrimidines as wee-1 inhibitors" was invented by Yuli Xie (Shanghai), Houxing Fan (Shanghai) and Lihui Qian (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel compound of general formula (1) and/or a pharmaceutically acceptable salt thereof, a composition containing the compound of general formula (1) and/or the pharmaceutically acceptable salt thereof, a method for preparing the same, and use of the same as a Wee-1 inhibitor in preparing anti-tumor drugs."

The patent was file...